商品簡介
This volume examines opportunities and challenges in public health genomics and the impact on wealth creation in various countries. It discusses genomics and genome sequencing; applications in public health; the genomic epidemiology of human papillomavirus (HPV), prostate cancer, and diabetes; the ethics of and research on neonatal screening for sickle cell anemia; biotechnology, human genome sequencing technologies, public health initiatives, and economic benefits in industrialized and developing countries; and biotechnology from plants, vegetables, and fruits with healing properties or medicinal value. Further chapters address genomic technologies in Brazil, Russia, India, China, and South Africa; the role of genomics and genetics in cardiovascular disease; innovating genomic technologies and technological challenges in developing countries; the economic benefits of the commercialization of genomic science; the impact of phenomenology, epigenome, and epigenetic factors on the growth and development of children; the H3Africa genomic program; microbial genomics in developed and developing countries; genetic nomenclature and quantitative techniques for scientists, clinicians, and educators; the role of the nursing profession in genomics medicine; and the role of venture capitalists, industries, and start-up companies in the commercialization of genomics science. Annotation c2016 Ringgold, Inc., Portland, OR (protoview.com)
